Basic Information
PRIMOVIST SOLUTION FOR INJECTION IN VIAL 0.25 mmol/ml
INJECTION, SOLUTION
Regulatory Information
SIN16559P
July 21, 2022
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
May 30, 2025
XV08CA10
Company Information
Active Ingredients
Gadoxetate, disodium
Strength: 0.25mmol/ml
Detailed Information
Contraindications
**4.3 Contraindications** None
Indication Information
**4.1 Indication** Primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (MRI) of focal liver lesions.